John A. Neczesny

Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information.

Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY.

Oberon Securities LLC provides financial advisory services. The firm addresses the financial needs of small and midsize companies in all industries. It also provides guidance on mergers and acquisitions, private placements, management buyouts, recapitalization, divestitures and sales, IPO's, cross border transactions, joint ventures, financings, restructurings, and valuations. The company was founded by Elad Epstein and Nicole Schmidt in 2001 and is headquartered in New York, NY.

Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ.

Blue Ox Healthcare partners LLC (Blue Ox Partners) is a private equity firm founded in 2009 by Oded Levy and Sheila Schweitzer. The firm is headquartered in New York.

Gemelli Biotech Corp. engages in the development and manufacture of antibody blood test products. The firm offers ibs-smart products. The company was founded by Matthew Mitcho, Ali Rezaie, Ruchi Mathur, and Mark Pimentel in 2018 and is headquartered in Los Angeles, CA.